Wockhardt Ltd 532300
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 538.05
- Day Range
- INR 530.25–562.00
- 52-Week Range
- INR 167.00–630.00
- Bid/Ask
- INR 0.00 / INR 0.00
- Market Cap
- INR 84.23 Bil
- Volume/Avg
- 22,767 / 59,978
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.80
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Wockhardt Ltd is a major drug manufacturing company with a focus on pharmaceutical and biotechnology products. The company conducts research in the fields of pharmaceuticals and biotechnology while also operating its chain of Super Specialty Hospitals. The vast majority of the company's revenue is generated in Europe. The company also operates in China, Japan, and Russia. The company's strategy includes the use of acquisitions, strategic partnerships, and contract manufacturing.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 3,143
- Website
- http://www.wockhardt.com
Comparables
Valuation
|
Metric
|
532300
|
524348
|
543434
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 25.51 | 24.67 |
Price/Book Value | 2.48 | 3.39 | 4.01 |
Price/Sales | 2.80 | 1.72 | 5.54 |
Price/Cash Flow | — | 19.30 | 28.18 |
Price/Earnings
532300
524348
543434
Financial Strength
|
Metric
|
532300
|
524348
|
543434
|
|---|---|---|---|
Quick Ratio | 0.31 | 0.91 | 3.14 |
Current Ratio | 0.76 | 1.66 | 6.26 |
Interest Coverage | −0.47 | 8.03 | 192.48 |
Quick Ratio
532300
524348
543434
Profitability
|
Metric
|
532300
|
524348
|
543434
|
|---|---|---|---|
Return on Assets (Normalized) | — | 7.10% | — |
Return on Equity (Normalized) | — | 13.89% | — |
Return on Invested Capital (Normalized) | — | 10.74% | — |
Return on Assets
532300
524348
543434
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Wkdxtvlkc | Vyt | $76.6 Bil | |
MKKGY
| Merck KGaA ADR | Nvkfprryl | Qgkhyy | $72.3 Bil | |
HLN
| Haleon PLC ADR | Fscxrjs | Lfdpr | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Jlxcydps | Nxtj | $18.3 Bil | |
VTRS
| Viatris Inc | Mzwyzqzt | Bkqb | $13.5 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Fqyfltgzg | Cbbtp | $11.8 Bil | |
CTLT
| Catalent Inc | Kvglfqgm | Mtxpj | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Fttjxkfq | Rymb | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Yvzsjgg | Dnxc | $4.2 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Hzfwzrlcj | Cdktpr | $3.5 Bil |